BigHat Biosciences logo

BigHat Biosciences

BigHat Biosciences is a company with a mission to enhance human health by making it easier to design advanced antibody therapeutics.

3

Funding Rounds

$99.3m

Money raised

Overview

BigHat Biosciences is a company with a mission to enhance human health by making it easier to design advanced antibody therapeutics.

Funding series

Funding Series Analysis

The company BigHat Biosciences has raised a total of $75m in funding over 3 rounds.

Key Insights:

  • BigHat Biosciences Series B round, July 20, 2022: $75m
  • BigHat Biosciences Series A round, February 2021: $19m
  • BigHat Biosciences Seed round, December 2019: $5.3m
BigHat Biosciences logo
BigHat Biosciences Series B round, July 20, 2022 $75m
BigHat Biosciences logo
BigHat Biosciences Series A round, February 2021 $19m
BigHat Biosciences logo
BigHat Biosciences Seed round, December 2019 $5.3m